Ozempic maker NovoNordisk on Wednesday said data showed ... Amycretin targets the same GLP-1 hormone as other weightloss and diabetes drugs like Novo’s Ozempic and Wegovy and Lilly’s ...
The new trial looked at liraglutide, the active ingredient used in two of NovoNordisk’s older GLP-1 drugs: Saxenda, a weightloss drug, and Victoza, a diabetes drug. Semaglutide, another ...
Results that may be inaccessible to you are currently showing.